Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: "Espelho, espelho meu"
Total 0 results
Nothing found
Sponsors and Collaborators
Epicentre, Paris, France.
wenbinlu
Zhijun Sun
Paul W. Read, MD
Jain, Isha, B.A., Massachusetts General Hospital, Harvard Medical School
NATURAmedicatrix Sàrl
Sociedad Española de Arteriosclerosis
Sonogenix
Dr Gilles DUCHEIX/ Center of clinical pharmacology/CIC Inserm-501 - Investigator
Health Holding Company, Hail Health Cluster, Saudi Arabia
Resurge Therapeutics Inc.
Prader-Willi Syndrome Association of Australia
Australian Childhood Foundation
Kettering Foundation
Laboratoires Iprad-Vegebom
The Depressive and Bipolar Disorder Alternative Treatment Foundation
Méthodologie et Evaluation pour la Recherche clinique et Epidémiologique sur le VIH en Afrique (MEREVA)
Remedy Institute
Brigham and Womens' Hospital, Center for Surgery and Public Health
Carlos III Health Institute
View Full List
Medical Conditions
Relapsed/Refractory Diffuse Large B-cell Lymphoma
Mycobacterium Avium Complex Infections
Stage III Childhood Anaplastic Large Cell Lymphoma
Intervention Studies
Hernia,Ventral
Stroke Recrudescence
Pregnancy; Accident
Stage IIIB Esophageal Adenocarcinoma
Cell Senescence
Spinocerebellar Ataxia Genotype Type 3
Ankle Trauma
Psychoactive Substance Use
Malignant Tumor of Extrahepatic Bile Duct
Adherence to In-Office Glaucoma Evaluation Appointment
Marginal Zone B-cell Lymphoma
Escape Room Games and Role Playing Gamification
Neurobehavioral Manifestation
Apneic; Oxygenation
Lymphoblastic Lymphoma
Refractory B-Lineage Lymphoma
View Full List
Drug Interventions
SBI-087
300 mg of caffeine citrate infusion
Fortum (Ceftazidime for injection USP) Glaxo Smith Kline Pharmaceuticals Limited
Low molecular weight Heparin as standard of care treatment
Lansoprazole 15mg QD
Fenofibric acid 135mg
FRSW107
ART-123
Colecalciferol D3 (Vigantol Oil)
Gadoteridol (ProHance)
Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
Optiva artificial tear by Allergan
Fostamatinib
Triple therapy
Omeprazole 40 mg
Irinotecan
Epalrestat
LINjeta U-100 Insulin
Oral Aztreonam
Everolimus
View Full List
CROs by country
Contract Research Organizations in Croatia
Contract Research Organizations in Gabon
Contract Research Organizations in Germany
Contract Research Organizations in Indonesia
Contract Research Organizations in Israel
Contract Research Organizations in Italy
Contract Research Organizations in Kuwait
Contract Research Organizations in Lithuania
Contract Research Organizations in Malaysia
Contract Research Organizations in Moldova
Contract Research Organizations in Qatar
Contract Research Organizations in Singapore
Contract Research Organizations in Slovakia
CRO list by country
CROs in United States
Mosio, Inc.
Premier Research
Unison
Burleson Research Technologies (BRT)
TAKE Solutions
Charles River Laboratories
ProTrials
Bradstreet Clinical Research
Parexel
MCRA
All CROs in United States
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe